These data indicated that the upregulated mRNA expression levels of HNRNPA0, HNRNPA2B1, HNRNPC, HNRNPD, PCBP1, HNRNPF, PTBP1, HNRNPK, HNRNPL, HNRNPM, SYNCRIP, HNRNPR, and HNRNPU were significantly associated with high cancer stages and lymph node metastases (LNM) with few exceptions. Here, HNRNPA2B1 is linked to metastatic malignant neoplasm in the lymph nodes.